OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480 | -12.7% | 38,846 | -36.2% | 0.00% | – |
| Q2 2023 | $550 | +170.9% | 60,853 | +4.4% | 0.00% | – |
| Q1 2023 | $203 | +20.8% | 58,300 | -14.9% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 68,500 | 0.0% | 0.00% | – |
| Q3 2022 | $190,000 | -31.9% | 68,500 | 0.0% | 0.00% | – |
| Q2 2022 | $279,000 | -7.6% | 68,500 | -3.3% | 0.00% | – |
| Q1 2022 | $302,000 | -54.0% | 70,872 | +1.0% | 0.00% | – |
| Q4 2021 | $657,000 | +172.6% | 70,172 | +713.8% | 0.00% | – |
| Q2 2021 | $241,000 | -13.9% | 8,623 | +2.0% | 0.00% | – |
| Q1 2021 | $280,000 | – | 8,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $103,181,000 | 7.44% |
| BVF INC/IL | 6,661,503 | $183,591,000 | 7.16% |
| VR Adviser, LLC | 1,536,193 | $42,337,000 | 5.44% |
| Cormorant Asset Management, LP | 3,073,485 | $84,705,000 | 3.44% |
| GREAT POINT PARTNERS LLC | 329,086 | $9,070,000 | 2.11% |
| Vivo Capital, LLC | 1,238,575 | $34,135,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 150,500 | $4,148,000 | 1.46% |
| Foresite Capital Management IV, LLC | 342,030 | $9,426,000 | 1.39% |
| RA Capital Management | 2,150,404 | $59,265,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 338,381 | $9,326,000 | 0.78% |